Staar Surgical (STAA) announced that its board of directors has authorized a share repurchase program under which the company may repurchase up to $30M of its outstanding common stock.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- STAAR Surgical’s Earnings Call: Growth Amid Challenges
- Staar Surgical: Hold Rating Amid Strong Q1 Performance and Strategic Adjustments
- Staar Surgical: Hold Rating Amidst Uncertainties and Strategic Adjustments
- Staar Surgical price target raised to $20 from $17 at Canaccord
- Cautious Outlook on Staar Surgical Amid Market Challenges and Guidance Withdrawal